Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19706807 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors
Conditions: Bladder Cancer;   Brain and Central Nervous System Tumors;   Breast Cancer;   Esophageal Cancer;   Extragonadal Germ Cell Tumor;   Gastric Cancer;   Lung Cancer;   Ovarian Cancer;   Prostate Cancer
Interventions: Drug: lapatinib;   Drug: paclitaxel

Indicates status has not been verified in more than two years